Trajenta®

Greater than 30 million patient-years of exposure in 110+ countries.

Boehringer Ingelheim has been dedicated to improving the lives of patients with cardiometabolic disease for more than 100 years.

Trajenta is manufactured in world class facilities providing consistently reliable and high quality products, from research and development to patient delivery.

Trajenta is a medication used to treat type 2 diabetes by lowering blood sugar levels in adults.